Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells: Activation by angiotensin II in hypertension

Circulation Research

Volumn 83, Issue 12, 1998, Pages 1271-1278

  Boulanger, Chantal M ^a,b,d   Heymes, Christophe ^a   Benessiano, Joëlle ^a   Geske, Robert S ^b   Lévy, Bernard I ^a   Vanhoutte, Paul M ^b,c  

^a INSERM   (France)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^d HÔPITAL LARIBOISIÈRE   (France)

Author keywords

AT1 receptor; cGMP; Contraction; Neuronal nitric oxide synthase; Nitric oxide synthase activity

Indexed keywords

ANGIOTENSIN; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0032576585     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.83.12.1271     Document Type: Article

References (38)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;299: 373-376.
2. Lüscher TF, Vanhoutte PM. Endothelium-derived relaxing factors. In: Lüscher TF, Vanhoutte PM, eds. The Endothelium: Modulator of Cardiovascular Function. Boca Raton. Fla: CRC Press; 1990:23-43.
3. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
4. Vane JR. The Croonian Lecture, 1993. The endothelium: maestro of the blood circulation. Philos Trans R Soc Lond B Biol Sci. 1994;343: 225-246.
5. Manabe K, Shirahase H, Usui H, Kurahashi K, Fujiwara M. Endothelium-dependent contractions induced by angiotensin I and angiotensin II in canine cerebral artery. J Pharmacol Exp Ther. 1989;251:317-320.
6. Lin L, Nasjletti A. Role of endothelium-derived prostanoid in angiotensin-indueed vasoconstriction. Hypertension. 1991;18:158-164.
7. Yen MH, Sheu YZ, Chiou WF Wu CC. Differential modulation by basilar and mesenteric endothelium of angiotensin-induced contraction in canine arteries. Eur J Pharmacol. 1990;180:209-216.
8. Bullock GR, Taylor SG, Weston AH. Influence of the vascular endothelium on agonist-induced contractions and relaxations in rat aorta. Br J Pharmacol. 1986;89:819-830.
9. Féletou M, Germain M, Teisseire B. Modulation of angiotensin-peptide-induced contraction by the vascular endothelium. J Vasc Med Biol. 1990;2:18-25.
10. 1-mediated release of nitric oxide decreases angiotensin II contractions in rat carotid artery. Hypertension. 1995;26:752-757.
11. 1 subtype receptors in rat carotid artery. Arterioscler Thromb Vasc Biol. 1995;15:1646-1651.
12. 1 receptors in endothelial cells. Br J Pharmacol. 1996; 118:79-84.
13. Boulanger CM, Geske RS, Lévy BI. Angiotensin II stimulates a neuronal like NO synthase in hypertensive vascular smooth muscle. Circulation. 1995;92:1-6. Abstract.
14. Lüscher TF, Diederich D, Weber E, Vanhoutte PM, Bühler FR. Endothelium-dependent response in carotid and renal arteries of normotensive and hypertensive rats. Hypertension. 1988;11:573-578.
15. 2+-independent nitric oxide synthetases. FEBS Lett. 1991;291:145-149.
16. Arunlakshana O, Schild OH. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959;14:48-58.
17. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res. 1980;47:1-9.
18. Rees DD, Palmer RMJ, Hodson HF, Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxations. Br J Pharmacol. 1989;96:418-424.
19. Moore PK, Babbedge RC, Wallace C, Gaffen, Hart SL. 7-Nitroindazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. J Pharmacol. 1993;108: 296-297.
20. Mayer B, Klatt P, Werner ER, Schmidt K. Identification of imidazole as L-arginine-competitive inhibitor of porcine brain nitric oxide synthase. FEBS Lett. 1994;350:199-202.
21. Martin W, Villani GM, Jothianandan D, Furchgott RF. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and methylene blue in the rabbit aorta. J Pharmacol Exp Ther. 1985;232:708-716.
22. Corbett JA, Tilton RG, Chang K, Hasan KS, Ido Y, Wang JL, Sweetland M, Lancaster JR Jr, McDaniel ML. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes. 1992;41:552-556.
23. G-methyl-L-arginine and aminoguanidine on constitutive and inducible nitric oxide synthase in rat aorta. Biochem Biophys Res Commun. 1994;199:147-154.
24. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol. 1986;250: H822-H827.
25. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived relaxing factor. Nature. 1986; 320:454-456.
26. Rees DD, Celleck S, Palmer RMJ, Moncada S. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem Biophys Res Commun. 1990;173:541-547.
27. Schini VB, Vanhoutte PM. L-Arginine evokes both endothelium-dependent and -independent relaxations in L-arginine depleted aortas of the rat. Circ Res. 1991;68:2009-2216.
28. Junquero DC, Schini VB, Scott-Burden T, Vanhoutte PM. Enhanced production of nitric oxide in aortae from spontaneously hypertensive rats by interleukin-1β. Am J Hypertens. 1993;6:602-610.
29. Scott-Burden T, Elizondo E, Ge T, Boulanger CM, Vanhoutte PM. Simultaneous activation of adenylyl cyclase and protein kinase C induces production of nitric oxide by vascular smooth muscle cells. Mol Pharmacol. 1994;46:274-282.
30. Mohaupt MG, Elzie JL, Ahn KY, Clapp WL, Wilcox CS, Kone BC. Differential expression and induction of mRNAs encoding two inducible nitric oxide synthases in rat kidney. Kidney Int. 1994;46:653-665.
31. Murthy KS, Makhlouf GM. Vasoactive intestinal peptide/pituitary adenylate cyclase activating peptide-dependent activation of a membrane-bound NO synthase in smooth muscle mediated by pertussis toxin-sensitive Gil-2. J Biol Chem. 1994;269:15977-15980.
32. Kobzik L, Reid MB, Bredt DS, Stamler JS. Nitric oxide in skeletal muscle. Nature. 1994;372:546-549.
33. Bernhardt J, Tschudi MR, Dohi Y, Gut I, Urwyler B, Buhler FR, Luscher TF. Release of nitric oxide from human vascular smooth muscle cells. Biochem Biophys Res Commun. 1991;180:907-912.
34. Tomimoto H, Nishimura M, Suenaga T, Nakamura S, Akiguchi I, Wachita H, Kimura J, Mayer B. Distribution of nitric oxide synthase in the human cerebral blood vessels and brain tissues. J Cereb Blood Flow Metab. 1994;14:930-938.
35. Iliano S, Marsault R, Descombes JJ, Verbeuren T, Vanhoutte PM. Regulation of nitric oxide-like activity by prostanoids in smooth muscle of the canine saphenous vein. Br J Pharmacol. 1996;117:360-364.
36. Loesch A, Burnstock G. Ultrastructural localization of nitric oxide synthase and endothelin in coronary and pulmonary arteries of newborn rats. Cell Tissue Res. 1995;249:475-483.
37. Cortes SD, Andriantsitohaina R, Stoclet JC. Alterations of cyclooxygenase products and NO in response to angiotensin II of resistance arteries from the spontaneously hypertensive rat. Br J Pharmacol. 1996;199: 1635-1641.
38. 2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest. 1997;100:264-269.